Thy-1 is a cell surface glycoprotein of unknown function that is found
on nerve cells and mature T-lymphocytes. To study the regulation of T
hy-1 gene expression, mouse Thy-1.2 genomic sequences were joined to v
arious marker sequences and the resulting chimeric constructs were use
d to produce nearly three dozen independent lines of transgenic mice.
The starting point for our studies was an 8.2 kb EcoRI fragment that b
egins 1.7 kb 5' to the transcription start site and ends with 1.3 kb o
f 3' flanking sequences. Addition of a small marker oligonucleotide to
the 3' untranslated region of this fragment had little or no effect o
n gene regulation. All of the lines derived from injection of this con
struct expressed the transgene in the appropriate tissues. Thus, as ex
pected, the Thy-1.2 genomic fragment contains all of the information n
ecessary for tissue-specific, position-independent expression of the m
odified transgene. Unexpectedly, Thy-1/lacZ hybrid genes did not mimic
this behavior. Using either mRNA or histochemical detection of lacZ p
rotein, these constructs were expressed in patterns that varied dramat
ically from line to line. This behavior suggests that integration site
-specific effects dominate the cis-active Thy-1 regulatory elements le
ading to wide variability of expression. This is further emphasized by
the observation that the bacterial reporter protein was found in a fe
w non-neuronal cell-types, in contrast to the known pattern of native
Thy-1 expression. These results suggest that either the Thy-1.2 sequen
ces which are necessary for appropriate brain-specific expression are
not contained solely within the proposed CNS enhancer in the first int
ron, or that fusion of the Thy-1.2 sequences with the lacZ coding regi
on may disrupt normal Thy-1 regulatory signals (or result in the creat
ion of new regulatory elements).